2
Supplementary Fig. S1. Calculation of P-score according to P-value. P-score is defined by the represented equation. The graph shows relationship between P-score and P -value; x-axis indicates P -value with log-scale and y-axis indicates P-score. For easy recognition of statistical significance, we projected P-score to 0.5 when P -value is 0.01. Evaluation of drug-targetable genes by defining modes of abnormality in gene expression Junseong Park * , Jungsul Lee, Chulhee Choi * 10 -10 10 -8 10 -6 10 -4 10 -2 10 0 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 P-value P-score P-score = sign(tg)×{1 – log 10 (P-value) } sign(tg) = +1, if tg expression in cancer in normal –1, if tg expression in cancer < in normal

Evaluation of drug-targetable genes by defining modes of ... fileECAD ITG8 ECM-receptor interaction CASP3 a-catenin b-catenin CR-AB Pl_cg Tissue invasion & metastasis Adherens

  • Upload
    vohanh

  • View
    214

  • Download
    0

Embed Size (px)

Citation preview

Supplementary Fig. S1. Calculation of P-score according to P-value.

P-score is defined by the represented equation. The graph shows relationship between P-score

and P-value; x-axis indicates P-value with log-scale and y-axis indicates P-score. For easy

recognition of statistical significance, we projected P-score to 0.5 when P-value is 0.01.

Evaluation of drug-targetable genes by defining modes of abnormality in

gene expression

Junseong Park*, Jungsul Lee, Chulhee Choi*

10 -10 10 -8 10 -6 10 -4 10 -2 10 00

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

P-value

P-sc

ore

P-score = sign(tg)×{1 – log10(P-value)}sign(tg) = +1, if tg expression in cancer ≥ in normal

–1, if tg expression in cancer < in normal

Drug targetability (merged from top 5% pairs)

Min value (0.340834) Max value (0.986393)

Supplementary Fig. S2. Cancer pathway overlaid with drug targetability values.

In the cancer pathway in the UnitPath database, node colors were overlaid with values of drug

targetability. The color map shows the minimum (white) to maximum (red) drug targetability

values.